FDA Advisory Committee To Review Genentech’s Avastin For Use As Breast Cancer Treatment
Genentech on Thursday announced that an FDA advisory panel in December will review its colon and lung cancer treatment Avastin as a first-line treatment for metastatic breast cancer, [click link for full article]
More: continued here